SteelPeak Wealth’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Hold
0
-$369K 484
2023
Q1
Hold
0
277

Other funds holding MRNA

SteelPeak Wealth's MRNA Position: Q2 2026 in Review

SteelPeak Wealth opened a new position in Moderna (MRNA) in Q2 2026: 3,270 shares worth $229K. The stake represents 0.01% of the portfolio and ranks #584 among its holdings. This is a return to the name: SteelPeak Wealth previously reported a position in MRNA as recently as Q3 2024.

SteelPeak Wealth first reported a position in MRNA in Q4 2020 and has held it in 17 quarters since. The position peaked at $8.59M in Q3 2021. 184 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • SteelPeak Wealth held 3,270 shares of Moderna worth $229K as of Q2 2026.
  • Moderna was a new SteelPeak Wealth position in Q2 2026.
  • Moderna made up 0.01% of SteelPeak Wealth's portfolio in Q2 2026, its #584 holding.
  • SteelPeak Wealth first reported a position in Moderna in Q4 2020 and has held it in 17 quarters since.
  • SteelPeak Wealth's Moderna position peaked at $8.59M in Q3 2021.
  • 184 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on SteelPeak Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.